ISOLATION OF A HUMAN HOMOLOGUE OF THE MURINE LY-6 SYSTEM
ISOLATION OF A HUMAN HOMOLOGUE OF THE MURINE LY-6 SYSTEM
批准号:
3085732
负责人:
Steven P. Balk
金额:
$5.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-08 至 1989-06-30
关键词:
T lymphocyte antibody formation complementary DNA gel electrophoresis gene expression genetic library genetic manipulation genetic transcription genetic transduction genetic translation histocompatibility antigens histocompatibility gene human tissue hybridomas immunochemistry immunofluorescence technique laboratory mouse laboratory rabbit leukocyte activation /transformation messenger RNA molecular cloning monoclonal antibody neoplasm /cancer genetics nucleic acid hybridization nucleic acid probes nucleic acid sequence phosphatidylinositols protein biosynthesis protein sequence radiotracer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The murine Ly-6 locus encodes a group of cell surface molecules
expressed on a variety of lymphoid, myeloid and other cell types.
At least two of these Ly-6 encoded molecules, Ly-6E.1 and TAP,
and involved in T lymphocytes activation. A cDNA for one of the
Ly-6 proteins was isolated recently and studies with this cDNA
confirm that Ly-6 is a complex multigene family. We propose to
use the murine cDNA to isolate and characterize a human
homologue of the murine Ly-6 system. The existence of human
sequences homologous to Ly-6 will be determined by probing
Southern blots of human genomic DNA with the murine Ly-6
cDNA. Cells expressing mRNA homologous to Ly-6 will be
identified by probing Northern blots with the Ly-6 cDNA. cDNA
libraries from cells expressing Ly-6 related messages will be
screened with the Ly-6 probe and homologous clones will be
isolated. These human cDNA's will be characterized by
restriction analysis and will be sequenced. Peptides will be
synthesized based on the deduced amino acid sequences and will
be used to generate specific antibodies. Full length cDNA's will
be expressed in expression vectors and the isolated proteins will
be used for structural studies and for the generation of specific
antibodies. These cDNA's and antibodies will be utilized for
studying the structure of the human Ly-6 system and the role it
plays in cellular activation.
The major long-term objective of this work is to identify and
characterize molecules involved in the process of transducing
extracellular messages and cellular activation. It has become
clear recently that adherent function or control of cellular
activation molecules may be an etiology for some or many human
malignancies. Moreover, activated lymphocytes are an important
new modality in the treatment of some human malignancies.
Elucidating the human Ly-6 system should further our
understanding of cancer and aid in its treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DF/HCC Prostate SPORE
-
批准号:10628270
-
项目类别:
-
资助金额:$258.56万
-
财政年份:2023
-
负责人:Steven P. Balk
-
依托单位:
WNT5a/ROR2-Mediated Hippo Pathway Activation in Prostate Cancer
-
批准号:10734173
-
项目类别:
-
资助金额:$39.55万
-
财政年份:2023
-
负责人:Steven P. Balk
-
依托单位:
Enhancing the Efficacy of Docetaxel in Prostate Cancer
-
批准号:10665071
-
项目类别:
-
资助金额:$64.14万
-
财政年份:2022
-
负责人:Steven P. Balk
-
依托单位:
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
-
批准号:10407648
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2021
-
负责人:Steven P. Balk
-
依托单位:
Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs
-
批准号:10279279
-
项目类别:
-
资助金额:$40.03万
-
财政年份:2021
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:9477598
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:8653225
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
SOX9 Mediation of AR and ERG Driven Prostate Cancer
-
批准号:9269164
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2014
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:8475909
-
项目类别:
-
资助金额:$218.35万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
-
批准号:10363640
-
项目类别:
-
资助金额:$23.74万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:10363638
-
项目类别:
-
资助金额:$142.94万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:10576935
-
项目类别:
-
资助金额:$143.19万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
-
批准号:10576938
-
项目类别:
-
资助金额:$23.75万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Basis for Androgen Receptor Antagonist Resistance in CRPC
-
批准号:8475911
-
项目类别:
-
资助金额:$29.28万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:8665884
-
项目类别:
-
资助金额:$201.08万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Core A: Administrative Core
-
批准号:10363642
-
项目类别:
-
资助金额:$8.66万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Androgen Receptor Action in Castration Resistant Prostate Cancer
-
批准号:9099781
-
项目类别:
-
资助金额:$204.51万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Administrative/Clinical/Biostatistics Core
-
批准号:8475914
-
项目类别:
-
资助金额:$14.15万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Core A: Administrative Core
-
批准号:10576941
-
项目类别:
-
资助金额:$8.82万
-
财政年份:2013
-
负责人:Steven P. Balk
-
依托单位:
Targeting androgen receptor signaling in prostate cancer in men with African ancestry
-
批准号:10490377
-
项目类别:
-
资助金额:$9.63万
-
财政年份:2010
-
负责人:Steven P. Balk
-
依托单位:
海外基金